Abstract
The fungal metabolite gliotoxin at low concentrations prevents mitogen stimulation of mature lymphocytes as a result of gliotoxin-induced genomic DNA degradation. Bone marrow, on the other hand, contains a subpopulation of cells resistant to gliotoxin at similar concentrations. This population includes the hemopoietic progenitor cells that grow in vitro in response to appropriate colony-stimulating factors and cells that form colonies in the spleens of lethally irradiated recipients. Gliotoxin treatment of lymph node cell-enriched bone marrow significantly delayed the onset of graft-versus-host disease in fully allogeneic bone marrow chimeras.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braithwaite A. W., Eichner R. D., Waring P., Müllbacher A. The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol. 1987 Jan;24(1):47–55. doi: 10.1016/0161-5890(87)90110-6. [DOI] [PubMed] [Google Scholar]
- Gale R. P., Reisner Y. Graft rejection and graft-versus-host disease: mirror images. Lancet. 1986 Jun 28;1(8496):1468–1470. doi: 10.1016/s0140-6736(86)91503-5. [DOI] [PubMed] [Google Scholar]
- Korngold R., Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med. 1978 Dec 1;148(6):1687–1698. doi: 10.1084/jem.148.6.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munday R. Studies on the mechanism of toxicity of the mycotoxin, sporidesmin. I. Generation of superoxide radical by sporidesmin. Chem Biol Interact. 1982 Sep;41(3):361–374. doi: 10.1016/0009-2797(82)90112-0. [DOI] [PubMed] [Google Scholar]
- Müllbacher A., Eichner R. D. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3835–3837. doi: 10.1073/pnas.81.12.3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müllbacher A., Waring P., Eichner R. D. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol. 1985 May;131(5):1251–1258. doi: 10.1099/00221287-131-5-1251. [DOI] [PubMed] [Google Scholar]
- Rayfield L. S., Brent L. The effect of T lymphocyte depletion on neonatal tolerance induction, graft-vs.-host disease and cellular chimerism. Eur J Immunol. 1984 Apr;14(4):308–313. doi: 10.1002/eji.1830140406. [DOI] [PubMed] [Google Scholar]
- Rayfield L. S., Brent L. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras. Transplantation. 1983 Aug;36(2):183–189. doi: 10.1097/00007890-198308000-00015. [DOI] [PubMed] [Google Scholar]
- Storb R., Thomas E. D. Allogeneic bone-marrow transplantation. Immunol Rev. 1983;71:77–102. doi: 10.1111/j.1600-065x.1983.tb01069.x. [DOI] [PubMed] [Google Scholar]
- TILL J. E., McCULLOCH E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961 Feb;14:213–222. [PubMed] [Google Scholar]
- Vallera D. A., Soderling C. C., Carlson G. J., Kersey J. H. Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone. Transplantation. 1981 Mar;31(3):218–222. doi: 10.1097/00007890-198103000-00015. [DOI] [PubMed] [Google Scholar]
- Waldmann H., Polliak A., Hale G., Or R., Cividalli G., Weiss L., Weshler Z., Samuel S., Manor D., Brautbar C. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet. 1984 Sep 1;2(8401):483–486. doi: 10.1016/s0140-6736(84)92564-9. [DOI] [PubMed] [Google Scholar]